Cetera Investment Advisers
VCYT icon

Cetera Investment Advisers’s Veracyte VCYT Stock Holding History

Cetera Investment Advisers’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
23,029
+14,500
+170% +$608K ﹤0.01% 2747
2026
Q1 		$275K Sell
8,529
-782
-8% -$28.9K ﹤0.01% 4061
2025
Q4 		$392K Buy
9,311
+120
+1% +$4.84K ﹤0.01% 3655
2025
Q3 		$316K Buy
+9,191
New +$264K ﹤0.01% 3785

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Cetera Investment Advisers's VCYT Position: Q2 2026 in Review

Cetera Investment Advisers increased its Veracyte (VCYT) stake by 170% in Q2 2026, buying an estimated $608K and bringing the position to 23,029 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2747.

Cetera Investment Advisers first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Cetera Investment Advisers held 23,029 shares of Veracyte worth $1.35M as of Q2 2026.
  • Cetera Investment Advisers bought 14,500 Veracyte shares in Q2 2026, an estimated $608K.
  • Veracyte made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2747 holding.
  • Cetera Investment Advisers first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.